• Developing topical live bacterial products for the treatment of skin diseases, beginning with fungal indications

  • Building a bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases

  • Mining our curated library of microbes to build a pipeline of products to treat identified dysbiosis across new indications